 | Arcturus Therapeutics Holdings | |||
| NGM : ARCT || Location: United States | ||||
$25.98-0.34 (-1.29%) |
0.62 M | 25.57 - 26.88 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 4.810 M |
| March 15, 2024 | 4.206 M |
| Feb. 29, 2024 | 4.219 M |
| Feb. 15, 2024 | 4.521 M |
| Jan. 31, 2024 | 4.369 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.01 | -0.32 | 68.38% |
| 09/30/2023 | -1.73 | -0.61 | 64.65% |
| 06/30/2023 | -0.22 | -1.98 | -820.93% |
| 03/31/2023 | 0.06 | 1.87 | 2970.61% |
| 12/31/2022 | 1.00 | 4.43 | 343.80% |
ARCT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 26.915M | Shares Float | 24.550M |
| Short Float | 4.810M | Market Cap | 708.40M |
| Institution ownership | 92.17% | Insider ownership | 8.748% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.12 | Forward EPS | 0.60 |